These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 36308318

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose.
    Tian H, Fang Y, Liu W, Wang J, Zhao J, Tang H, Yin Y, Hu Y, Peng J.
    J Ethnopharmacol; 2023 Jan 30; 301():115806. PubMed ID: 36216198
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver].
    Li HS, Feng Q, Hu YY, Chen SD, Peng JH, Li XM, Xu LL.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 30; 17(11):826-30. PubMed ID: 19958641
    [Abstract] [Full Text] [Related]

  • 6. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis].
    Zhang H, Feng Q, Li HS, Chen SD, Wang XN, Peng JH, Zhang N, Hu YY.
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep 30; 6(9):928-33. PubMed ID: 18782536
    [Abstract] [Full Text] [Related]

  • 7. Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase In Vivo and In Vitro.
    Feng Q, Gou XJ, Meng SX, Huang C, Zhang YQ, Tang YJ, Wang WJ, Xu L, Peng JH, Hu YY.
    Evid Based Complement Alternat Med; 2013 Sep 30; 2013():184358. PubMed ID: 23573117
    [Abstract] [Full Text] [Related]

  • 8. A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet.
    Gou XJ, Gao S, Chen L, Feng Q, Hu YY.
    Biomed Res Int; 2019 Sep 30; 2019():5920485. PubMed ID: 30881991
    [Abstract] [Full Text] [Related]

  • 9. [Effect of qushl huayu decoction on high-fat diet induced hepatic lipid deposition in rate].
    Li HS, Feng Q, Hu YY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Dec 30; 29(12):1092-5. PubMed ID: 20214330
    [Abstract] [Full Text] [Related]

  • 10. Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.
    Feng Q, Liu W, Baker SS, Li H, Chen C, Liu Q, Tang S, Guan L, Tsompana M, Kozielski R, Baker RD, Peng J, Liu P, Zhu R, Hu Y, Zhu L.
    Oncotarget; 2017 Apr 25; 8(17):27820-27838. PubMed ID: 28416740
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic Effect of HGF on NASH Mice Through HGF/c-Met and JAK2-STAT3 Signalling Pathway.
    Li N, Dou Z, Liu J, Chai B, Li Y, An X, Chu P, Zhang X.
    Ann Hepatol; 2018 Apr 25; 17(3):501-510. PubMed ID: 29735799
    [Abstract] [Full Text] [Related]

  • 12. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS, Song JW, Park JH, Lim BK, Moon OS, Son HY, Lee JH, Gao B, Won YS, Kwon HJ.
    Autophagy; 2021 Sep 25; 17(9):2549-2564. PubMed ID: 33190588
    [Abstract] [Full Text] [Related]

  • 13. [Inhibitory effects of Qushi Huayu Decoction on fatty deposition and tumor necrosis factor alpha secretion in HepG2 cells induced by free fatty acid].
    Zhang H, Hu YY, Feng Q.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec 25; 27(12):1105-9. PubMed ID: 18198645
    [Abstract] [Full Text] [Related]

  • 14. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T, Ishigami M, Luo F, Lingyun M, Ishizu Y, Kuzuya T, Hayashi K, Nakano I, Ishikawa T, Feng GG, Katano Y, Kohama T, Kitaura Y, Shimomura Y, Goto H, Hirooka Y.
    Metabolism; 2017 Apr 25; 69():177-187. PubMed ID: 28285648
    [Abstract] [Full Text] [Related]

  • 15. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.
    Fredrickson G, Barrow F, Dietsche K, Parthiban P, Khan S, Robert S, Demirchian M, Rhoades H, Wang H, Adeyi O, Revelo XS.
    Mol Metab; 2021 Nov 25; 53():101270. PubMed ID: 34118476
    [Abstract] [Full Text] [Related]

  • 16. Qushi Huayu Decoction (祛湿化瘀方) inhibits protein and gene expression of cathepsin B in HepG2 cells induced by free fatty acids.
    Feng Q, Cheng Y, Hu YY, Zhang H, Peng JH, Zhang N.
    Chin J Integr Med; 2010 Dec 25; 16(6):518-24. PubMed ID: 21110177
    [Abstract] [Full Text] [Related]

  • 17. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
    Gao SS, Sun JJ, Wang X, Hu YY, Feng Q, Gou XJ.
    Biomed Res Int; 2020 Dec 25; 2020():1704960. PubMed ID: 33204683
    [Abstract] [Full Text] [Related]

  • 18. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X, Meng Q, Wang C, Liu Z, Liu Q, Sun H, Sun P, Yang X, Huo X, Peng J, Liu K.
    Phytomedicine; 2017 Feb 15; 25():83-92. PubMed ID: 28190475
    [Abstract] [Full Text] [Related]

  • 19. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
    Cai X, Fang C, Hayashi S, Hao S, Zhao M, Tsutsui H, Nishiguchi S, Sheng J.
    J Gastroenterol; 2016 Aug 15; 51(8):819-29. PubMed ID: 26794005
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.